TwitterLinkedin

Contact Us

  • News & Events
    • News
    • Webinars
    • Events
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Working at PharmaLex
    • Your Application Process
    • Current Opportunities
  • Training
Top Bar
Search
PharmaLex Logo
MENUMENU
  • PharmaLex Logo
  • PharmaLex Logo
  • About UsAbout Us
    • About Us
    • Management Team
    • What Our Clients Say About Us
  • Our Services
    • Discovery / Non-clinical

          • Go to Discovery / Non-clinical section >>

          • Strategy and Consulting

            • Development Strategy and Gap Analysis
            • Integrated Product Development
            • Market Access Strategy
            • Non-clinical Development Concept
              and Study Design
            • Scientific Advice
            • Scientific Due Diligence
            • Statistical Services
            • Toxicology Services
    • Clinical Development

          • Go to Clinical Development section >>

          • Strategy and Consulting

            • Artificial Intelligence and Data Science
            • Clinical Program Development
            • Orphan Drug Designation
            • Pediatric Investigation Plan (PIP)
            • Scientific Advice
            • Statistical Services

          • Regulatory Affairs

            • Clinical Trial Applications (CTA)
            • Global Procedure Management
            • Health Authority / Agency Interaction

          • Pharmacovigilance

            • Clinical Trial Safety Support
            • Pharmacovigilance Consulting

          • Quality

            • GxP Services
            • IMP Management
            • Interim / Contract QA
            • Quality Systems
            • Tech Transfer / Scale-up
            • Vendor Management and Oversight
    • Authorization / Approval

          • Go to Authorization / Approval section >>

          • Strategy and Consulting

            • Market Access

          • Regulatory Affairs

            • CMC Services
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Scientific, Regulatory and Technical Writing
            • Statistical Services

          • Pharmacovigilance

            • EU QPPV / National QPPV
            • Pharmacovigilance Consulting
            • Risk Management Support

          • Quality

            • Commercialization Readiness
            • GxP Services
            • Interim / Contract QA
            • PAI Readiness
            • Validation
    • Post-approval / Maintenance

          • Go to Post-approval / Maintenance section >>

          • Strategy and Consulting

            • Environmental Risk Assessment
            • Market Access

          • Regulatory Affairs

            • CMC Services
            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Mergers and Acquisitions (M&A) Transfers
            • Toxicology Services

          • Pharmacovigilance

            • Audit and CAPA Management
            • EU QPPV / National QPPV
            • ICSR Management
            • Literature Screening
            • Pharmacovigilance Systems
            • Safety Writing (PSUR, RMP)
            • Signal Management

          • Quality

            • Commissioning and Qualification
            • Good Distribution Practice (GDP) Compliance
            • GxP Services
            • Interim / Contract QA
            • Quality Systems
            • Validation
            • Vendor Audit
            • Vendor Management and Oversight

          • Medical Affairs

            • Medical Information
    • Program Management

          • Go to Program Management section >>

          • Program Management

            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Integrated Product Development
            • Mergers and Acquisitions (M&A) Transfers
    • Featured Expertise

          • Industry Expertise

            • Biopharmaceuticals
            • Consulting
            • Consumer Healthcare
            • Generics
            • Herbal Medicines
            • Medical Device Services
            • Medicinal Products
            • Pharmaceutical
            • Veterinary Drugs

          • Service Expertise

            • ATMP / Cell and Gene Therapy
            • Brexit
            • COVID-19 Support
            • Drug Re-purposing / Value-added Medicines
            • GxP Services
            • Market Access
            • Pharmacoepidemiology
            • Statistical Services
            • Supporting Rx to OTC switches
            • Technology Enabled Services
  • Global ReachGlobal Reach
  • Contact usContact us
  • News & Events
    • News
    • Webinars
    • Events
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Working at PharmaLex
    • Your Application Process
    • Career Opportunities
  • Training
Home > News & Events

News & Events

Marketing a drug in France, what are the responsibilities of an exploitant?

Marketing a drug in France, what are the responsibilities of an exploitant?

16th September 2020

Brexit transition period drawing to a close

Brexit transition period drawing to a close

15th September 2020

Utmost priority – ensuring the supply of medicinal products and medical devices.

Utmost priority – ensuring the supply of medicinal products and medical devices.

10th September 2020

Taking a pragmatic approach to Brexit

Taking a pragmatic approach to Brexit

9th September 2020

BREXIT: Medical Device/Combination Products – Key changes

BREXIT: Medical Device/Combination Products – Key changes

3rd September 2020

BREXIT: Pharmacovigilance – Key changes

BREXIT: Pharmacovigilance – Key changes

3rd September 2020

BREXIT: Pharmaceutical Products and Import/Export – Key Changes

BREXIT: Pharmaceutical Products and Import/Export – Key Changes

3rd September 2020

BREXIT: Clinical Trials – Key changes

BREXIT: Clinical Trials – Key changes

3rd September 2020

Society of Quality Assurance (SQA) Virtual Meeting and Quality College 2020

Society of Quality Assurance (SQA) Virtual Meeting and Quality College 2020

2nd September 2020

Forum Institut für Management: eSubmissions – Ihre To-dos 2021

Forum Institut für Management: eSubmissions – Ihre To-dos 2021

28th August 2020

Biotech Atelier

Biotech Atelier

26th August 2020

First approved application for BioBag® medicinal larvae for Biomonde GmbH

First approved application for BioBag® medicinal larvae for Biomonde GmbH

25th August 2020

Clinical trials in the post Brexit Europe

Clinical trials in the post Brexit Europe

24th August 2020

Supporting Mergers and Acquisitions in the Pharmaceutical / Biopharmaceutical Industry

Supporting Mergers and Acquisitions in the Pharmaceutical / Biopharmaceutical Industry

24th August 2020

QbD and process Characterization

QbD and process Characterization

19th August 2020

Applied AI for Pharmaceutical R&D

Applied AI for Pharmaceutical R&D

19th August 2020

Global collaboration key as COVID-19 ramps up the pressure

Global collaboration key as COVID-19 ramps up the pressure

5th August 2020

PharmaLex strengthens its commercial organization

PharmaLex strengthens its commercial organization

4th August 2020

Sterility Assurance for pharmaceuticals

Sterility Assurance for pharmaceuticals

4th August 2020

KENX Validation and GMP University

KENX Validation and GMP University

29th July 2020

EU IDMP/SPOR Implementation Guide – version 2 released

EU IDMP/SPOR Implementation Guide – version 2 released

17th July 2020

PharmaLex further strengthens its capabilities in Regulatory Affairs and Pharmacovigilance

PharmaLex further strengthens its capabilities in Regulatory Affairs and Pharmacovigilance

15th July 2020

KENX Risk-Based Supply Chain Validation & Verification

KENX Risk-Based Supply Chain Validation & Verification

9th July 2020

Medical Device Regulation – Article 117 Action Required

Medical Device Regulation – Article 117 Action Required

23rd June 2020

Medical Device Regulation implementation – One year to go!

Medical Device Regulation implementation – One year to go!

4th June 2020

Comprehensive toxicology services to meet your GMP requirements

Comprehensive toxicology services to meet your GMP requirements

1st June 2020

The Medical Device Regulation & COVID-19

The Medical Device Regulation & COVID-19

20th May 2020

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19

6th May 2020

Auditing during Covid-19 pandemic – How do we keep on track?

Auditing during Covid-19 pandemic – How do we keep on track?

15th April 2020

Nitrosamines – NEW DEADLINE for Marketing Authorization Holders

Nitrosamines – NEW DEADLINE for Marketing Authorization Holders

14th April 2020
Upcoming Webinars

September 29th, 2020

QbD and process Characterization

October 8th, 2020

Marketing a drug in France, what are the responsibilities of an exploitant?

December 8th, 2020

Applied AI for Pharmaceutical R&D

Upcoming Events

September 24 - 25th, 2020

Biotech Atelier

September 21 - 29th, 2020

Society of Quality Assurance (SQA) Virtual Meeting and Quality College 2020

October 5 - 7th, 2020

TOPRA Symposium 2020

Visit us at booth #37

Recent News
  • Brexit transition period drawing to a close
    15th September 2020
  • Utmost priority – ensuring the supply of medicinal products and medical devices.
    10th September 2020
  • Taking a pragmatic approach to Brexit
    9th September 2020
  • BREXIT: Medical Device/Combination Products – Key changes
    3rd September 2020
  • BREXIT: Pharmacovigilance – Key changes
    3rd September 2020
  • BREXIT: Pharmaceutical Products and Import/Export – Key Changes
    3rd September 2020
Categories
  • All News
  • Webinars
  • Events
Archive
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
Tweets by @PharmaLexGLOBAL
COVID-19 NEWSLETTER SIGN UP

SIGN UP NOW

WHAT OUR CLIENTS SAY

  • I just wanted to let you know that the recent EU Codes webinar was excellent. Rina presented a very complex and grey topic in the most clear and digestible manner – a sign of a true expert. The questions in the Q&A were sometimes a little ambiguous but Rina gave clear and relevant answers that provided real clarity.

    Richard Blackwell
    Medical Team Leader, Multi Tumor Franchise Roche Products Ltd
PharmaLex
©2020 PharmaLex GmbH. All rights reserved.

ISO9001:2015 LogoEnergie Audit Logo

#AskTheExpert #TogetherBEYONDCOVID19





Select your state:

.
You can unsubscribe at any time at data.protection@pharmalex.com

If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

#TogetherBEYONDCOVID19

We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for

Please DO NOT send us event/conference information.
We will not respond and these will be deleted immediately.





Select your state:

.
You can unsubscribe at any time at data.protection@pharmalex.com

If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

Privacy Policy

This can be specific information about signing up to the newsletter.

Pellentesque lobortis, tellus at ultrices ullamcorper, lectus tellus consectetur lectus, id consequat leo quam quis eros. Mauris pellentesque tortor a augue pellentesque ultricies. Phasellus sit amet suscipit orci, vel dapibus ligula. Maecenas at pellentesque lectus, sit amet tristique felis. Integer fringilla risus ac neque mollis, at imperdiet lacus sodales. In vehicula orci sed vulputate interdum. Nunc sagittis non nunc eget sollicitudin.

Maecenas a mattis erat. Phasellus cursus erat non nisl pulvinar ultricies. Aenean id fringilla libero. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Morbi in ultrices elit. Suspendisse egestas hendrerit est. Integer pellentesque nisl ut justo tempus, nec suscipit dolor luctus. Cras vestibulum elementum tincidunt.

In compliance with the Spanish Law 15/1999, of Protection of Personal Data and in accordance with regulations approved by the Spanish RD 994/1999 inform you that your data will be part of a file located in Friedrichsdorf (Germany), whose ownership belongs to Pharmalex Spain S.L.U. The purpose of these data is the insertion in a potential job selection process. Inform the user that at any time may exercise their right of access, rectification, and deletion of data through email curriculum@pharmalex.com or to this postal address Pharmalex Spain. Coso 103, 50001 Zaragoza, Spain.